Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

A U.S. judge upheld two patents relating to Amgen Inc.’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG, which is seeking to launch a copycat version.

Read More »

In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million

A California judge reduced a $2 billion jury verdict, slashing the award for a couple who blamed Bayer AG’s glyphosate-based weed killer Roundup for their cancer to $86.7 million.

Read More »

San Francisco bans e-cigarette sales

San Francisco is the first major city in the United States to ban the sale of e-cigarettes as officials look to control the rapid uptick in teenage use of nicotine devices made by companies such as Juul Labs Inc.

Read More »

WHO Removes Controversial Opioid Guidelines Following Scathing Congressional Report

After accusations of being influenced by Purdue Pharma, the World Health Organization (WHO) withdrew two guidelines for opioid medications following criticism from U.S. lawmakers.

Read More »

Four Investors Indicted on Federal Fraud Charges Involving Vermont Biotech Company

A federal grand jury recently filed criminal charges against several developers for fraud involving a Vermont biotech company.

Read More »

Catalyst Pharma sues FDA over approval of cheaper rival drug

Catalyst Pharmaceuticals Inc., under fire for a high price tag on a rare disease drug, sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival medicine.

Read More »

Sanofi loses German patent case against Amgen over cholesterol drug

Germany’s highest civil court rejected French drugmaker Sanofi’s bid to fend off a legal challenge by U.S. rival Amgen against Sanofi’s cholesterol drug Praluent.

Read More »

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharmaceutical agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that the world’s largest generic manufacturer and other drugmakers helped fuel the U.S. opioid epidemic.

Read More »

Oklahoma takes on drugmakers J&J, Teva in landmark opioid trial

Oklahoma Attorney General Mike Hunter’s $17 billion lawsuit is the first to go to trial of more than 2,000 actions by state and local governments accusing opioid manufacturers of contributing to an epidemic linked to a record 47,600 overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention.

Read More »

Mallinckrodt sues U.S. health agencies, sees 10% hit to MS treatment sales

Mallinckrodt Plc filed a lawsuit against the U.S. Department of Health and Human Services and forecast an about 10 percent hit to annual net sales of the company’s gel used to treat multiple sclerosis symptoms following changes to Medicaid rebate calculations, sending shares plunging as much as 34 percent.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom